 |
 |

Diffusion-Tensor Magnetic Resonance Imaging Detects Normal-Appearing White Matter Damage Unrelated to Short-term Disease Activity in Patients at the Earliest Clinical Stage of Multiple Sclerosis
Antonio Gallo, MD;
Marco Rovaris, MD;
Roberto Riva, MD;
Angelo Ghezzi, MD;
Beatrice Benedetti, MD;
Vittorio Martinelli, MD;
Andrea Falini, MD;
Giancarlo Comi, MD;
Massimo Filippi, MD
Arch Neurol. 2005;62:803-808.
Background Diffusion-tensor (DT) magnetic resonance imaging (MRI) has the potential to elucidate some characteristics of tissue microstructure inaccessible to other MRI techniques.
Objective To investigate whether normal-appearing brain tissue abnormalities occur in patients with multiple sclerosis at the earliest clinical stage and whether their severity is predictive of a short-term disease evolution by using DT MRI.
Design Forty-five patients and 22 healthy control subjects were studied. All patients had had a clinically isolated syndrome within the 3 months preceding study enrollment and paraclinical evidence of disease dissemination in space. During a single session, dual-echo, pulsed-gradient spin-echo echo-planar, and postgadolinium T1-weighted images of the brain were obtained from each subject. In patients, dual-echo and enhanced images were obtained after 3 and 12 months, to detect MRI signs of disease dissemination in time. An on-study neurological examination was also conducted to ascertain the occurrence of clinical relapses. Mean diffusivity and fractional anisotropy maps were derived from DT images. Normal-appearing white matter (NAWM) and normal-appearing gray matter mean diffusivity and fractional anisotropy histograms were produced and analyzed.
Results During the study period, 29 patients showed MRI evidence of disease dissemination in time. When compared with healthy controls, patients showed higher average NAWM mean diffusivity (P = .01), lower average NAWM mean diffusivity peak height (P < .001), and fractional anisotropy (P < .001). The DT MRI characteristics of patients did not differ between those with and those without disease dissemination in time at follow-up.
Conclusions In patients with multiple sclerosis at the earliest clinical stage, the severity of NAWM damage does not predict new lesion formation in the short term, suggesting that the "diffuse" component of tissue damage is, at least partially, independent of the "discrete," predominantly inflammatory aspects of the disease since its clinical onset.
Author Affiliations: Neuroimaging Research Unit (Drs Gallo, Rovaris, Benedetti, and Filippi), Department of Neurology (Drs Rovaris, Benedetti, Martinelli, Comi, and Filippi), and Department of Neuroradiology (Drs Riva and Falini), Scientific Institute and University Ospedale San Raffaele, Milan; Department of Neurology, Second University of Naples, Naples (Dr Gallo); and Multiple Sclerosis Center, Ospedale di Gallarate, Gallarate (Dr Ghezzi), Italy.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Early treatment of multiple sclerosis: a Latin American Experts Meeting
Garcea et al.
Mult Scler 2009;15:S1-S12.
ABSTRACT
Magnetic resonance evidence of cortical onset of multiple sclerosis
Calabrese and Gallo
Mult Scler 2009;15:933-941.
ABSTRACT
A Diffusion Longitudinal MR Imaging Study in Normal-Appearing White Matter in Untreated Relapsing-Remitting Multiple Sclerosis
Garaci et al.
Am. J. Neuroradiol. 2007;28:475-478.
ABSTRACT
| FULL TEXT
What Causes Multiple Sclerosis to Worsen?
Phillips
Arch Neurol 2007;64:167-168.
FULL TEXT
MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis.
Agosta et al.
Am. J. Neuroradiol. 2006;27:892-894.
ABSTRACT
| FULL TEXT
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Frohman et al.
Arch Neurol 2006;63:614-619.
FULL TEXT
Diffusion MRI in multiple sclerosis
Rovaris et al.
Neurology 2005;65:1526-1532.
ABSTRACT
| FULL TEXT
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution
Rovaris et al.
Neurology 2005;65:1626-1630.
ABSTRACT
| FULL TEXT
|